Molecular Modeling and Drug Design: A Contemporary Analysis in Vibrio cholerae
Vibrio cholerae causes the diarrheal disease cholera. This microbe inhabits well in human host and aquatic environments. Excessive use of antibiotics has contributed to the emergence of antibiotic resistance in V. cholerae. Quorum sensing is one of the lucrative targets presently pursued for drug design in bacteria to encounter virulence. LuxO, a response regulator, is an important part of quorum-sensing machinery in V. cholerae contributing in biofilms and virulence machinery. In this chapter, we will concisely discuss the disease, its clinical display, and distinctive methodologies to find drug targets. As a treatise on the method of drug design in V. cholerae, we used our in silico model of LuxO in this chapter, to predict probable sites of interference, and then used these sites for in silico drug design.
KeywordsVibrio cholerae Drug design Novel drug targets Quorum sensing
- Howard Jones N (1979) Cholera nomenclature and nosology; a historical note. Bull WHO 51:317–324Google Scholar
- Huq A et al (1984b) The role of planktonic copepods in the survival and multiplication of Vibrio cholerae in the aquatic environment. In: Colwell RR (ed) Vibrios in the environment. Wiley, New York, pp 521–534Google Scholar
- Levine MM, Tacket CO (1994) Recombinant live cholera vaccines. In: Wachsmuth IK, Blake PA, Olsvik O (eds) Vibrio cholerae and cholera: molecular to global perspectives. American Society for Microbiology, Washington, DC, pp 39–415Google Scholar
- Ramamurthy T (2008) Antibiotic resistance in Vibrio cholera. In: Faruque SM, Nair GB (eds) Vibrio cholerae: genomics and molecular biology. Caister Academic Press, London, pp 191–207Google Scholar
- Tacket CO et al (1999) Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor Inaba three months after vaccination. Infect Immun 67:6341–6345PubMedPubMedCentralGoogle Scholar